Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline    GSK   GB0009252882

News SummaryMost relevantAll newsSector newsTweets 

GlaxoSmithKline Buys Back 1.3 Million Shares

share with twitter share with LinkedIn share with facebook
share via e-mail
05/04/2012 | 06:28pm CEST

GlaxoSmithKline PLC (>> GlaxoSmithKline plc) said Friday it has purchased 1,300,000 ordinary shares to be held in treasury.


-Highest price paid: 1455 pence per share.

-Lowest price paid: 1425 pence per share.

-Shares at 1610 GMT down 1%, at 1427 pence, valuing the company at GBP72 billion.

-By Mark Shapland, Dow Jones Newswires; +44 207 8429358; [email protected]

Stocks mentioned in the article : GlaxoSmithKline plc, GlaxoSmithKline plc
share with twitter share with LinkedIn share with facebook
share via e-mail
03:02p GLAXOSMITHKLINE : reports positive results with its shingles vaccine
06/21DJGLAXOSMITHKLINE : Shingles Treatment Meets Objective in Phase III Trial
06/16 GLAXOSMITHKLINE : GSK announces results from 10-year continuation study showing ..
06/16 Aspen loses Italy appeal over cancer drug prices
06/15 GLAXOSMITHKLINE : Researchers from GlaxoSmithKline plc Report Findings in Vaccin..
06/15 GLAXOSMITHKLINE : Study Data from Harvard School of Medicine Update Knowledge of..
06/15 GLAXOSMITHKLINE : Findings from GlaxoSmithKline plc Update Understanding of Anti..
06/15 GLAXOSMITHKLINE : Sandoz Latest to Go for Elusive Approval of Advair Generic
06/13 FTSE held back by sterling bounce as tech stocks recover
06/12DJGLAXOSMITHKLINE : Reports Positive Results For Malaria Treatment
More news
Sector news : Pharmaceuticals - NEC
10:57a Oil keeps a lid on European shares, Novartis drives health stocks
08:48aDJR. JOHNSON : Missouri Sues Drug Firms Over Opioid Marketing -- WSJ
06/21 Healthcare stocks rally as Senate set to unveil bill
06/21DJJOHNSON & JOHNSON : J&J Seeking Dismissal of Talc Lawsuits in Missouri
06/21DJR. JOHNSON : Missouri Files Its Own Suit Against Opioid-Painkiller Producers -- ..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
10:13a GILEAD : The Conundrum
07:55a Only Bristol Bucks Big Pharma's Drive For External Reliance
06/21 FDA aims at removing barriers to generic drug competition
06/21 Glaxo's shingles vaccine triggers immune response in elderly patients previou..
06/19 Glaxo and AstraZeneca settle dispute over star Luke Miels, tenure at GSK star..
Financials ( GBP)
Sales 2017 30 187 M
EBIT 2017 8 314 M
Net income 2017 4 337 M
Debt 2017 13 929 M
Yield 2017 4,75%
P/E ratio 2017 19,00
P/E ratio 2018 16,60
EV / Sales 2017 3,20x
EV / Sales 2018 3,09x
Capitalization 82 768 M
More Financials
Duration : Period :
GlaxoSmithKline Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 29
Average target price 17,9  GBP
Spread / Average Target 6,3%
Consensus details
EPS Revisions
More Estimates Revisions
Emma Walmsley Chief Executive Officer & Executive Director
Philip Roy Hampton Non-Executive Chairman
Simon Dingemans Chief Financial Officer & Executive Director
Patrick J. T. Vallance Executive Director, President-R&D
Roy Malcolm Anderson Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON16.50%361 566
ROCHE HOLDING LTD.8.81%224 305
NOVARTIS7.69%214 091
PFIZER4.31%199 854
MERCK AND COMPANY11.19%176 500
More Results